110

resultat

Ord
Publikationstyp
Politikområde
Författare
Sökord
Datum

Limits on exposure to carcinogens and mutagens at work: Third proposal

30-08-2019

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three proposals. Reacting to the Commission's set of measures as a whole, trade unions have acknowledged the importance of further improving the existing framework. Actors on the employers' side have underlined the need to ensure that values are proportionate and feasible in terms of technical implementation. After adoption by the Parliament and Council, in March and May respectively, based on a text agreed in trilogue in January 2019, the final act was signed by the presidents of the co-legislators on 5 June 2019. Directive (EU) 2019/983 entered into force on 10 July 2019 and is to be transposed into national law within two years, by 11 July 2021. Third edition. The 'EU Legislation in Progress' briefings are updated at key stages throughout the legislative procedure.

Endocrine disruptors: An overview of latest developments at European level in the context of plant protection products

25-04-2019

Endocrine disruptors (EDs) are chemical substances present in many products of daily life, which interact with the hormonal system and can disrupt its proper functioning. There is a growing interest in understanding EDs and progress has been made on both the scientific and regulatory side, but the topic remains of high concern at decision-making and societal levels because of the challenges it still poses. This paper provides a desk-research based overview of the key moments of the (scientific and ...

Endocrine disruptors (EDs) are chemical substances present in many products of daily life, which interact with the hormonal system and can disrupt its proper functioning. There is a growing interest in understanding EDs and progress has been made on both the scientific and regulatory side, but the topic remains of high concern at decision-making and societal levels because of the challenges it still poses. This paper provides a desk-research based overview of the key moments of the (scientific and regulatory) debate on EDs, with a focus on the latest developments at European level, namely Commission Regulation (EU) 2018/605 and the 2018 Commission communication ‘Towards a comprehensive European Union framework on endocrine disruptors’, in the particular context of plant protection products (PPPs).

What if a simple DNA test could predict your future?

22-03-2019

What if new-born babies were given a DNA report card that predicted their intelligence, their odds of getting a PhD, their chances of becoming a chain smoker or suffering depression, a heart attack or cancer? Thanks to ongoing genetic studies, a large amount of genetic data is available today involving millions of people. The wealth of information available to researchers allows them to create a polygenic risk score based on the DNA test of a person. This can be used to predict a person's chances ...

What if new-born babies were given a DNA report card that predicted their intelligence, their odds of getting a PhD, their chances of becoming a chain smoker or suffering depression, a heart attack or cancer? Thanks to ongoing genetic studies, a large amount of genetic data is available today involving millions of people. The wealth of information available to researchers allows them to create a polygenic risk score based on the DNA test of a person. This can be used to predict a person's chances of getting a disease, his or her traits and behaviour, and many other things about their future. Are these predictions flawless? Who would benefit from them? What are their implications for a person's life in general?

Protecting workers against carcinogens and mutagens: Third proposal

20-03-2019

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the ...

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the March II plenary session.

Mobile phones and health: Where do we stand?

20-03-2019

Mobile phones are an integral part of everyday life, and it is hard to imagine a world without them. There are nevertheless health concerns, and the debate is ongoing. There is a vast body of research on the potential risks from exposure to radiofrequency electromagnetic fields such as those emitted by mobile phones. Yet scientific opinion remains split over the possibility of a link between mobile phone radiation and health problems. The results of research in this area have been interpreted in ...

Mobile phones are an integral part of everyday life, and it is hard to imagine a world without them. There are nevertheless health concerns, and the debate is ongoing. There is a vast body of research on the potential risks from exposure to radiofrequency electromagnetic fields such as those emitted by mobile phones. Yet scientific opinion remains split over the possibility of a link between mobile phone radiation and health problems. The results of research in this area have been interpreted in a variety of ways, and studies have been criticised for their methodological flaws, lack of statistical significance, and bias. In 2011, the International Agency for Research on Cancer, a branch of the World Health Organization, classified radiofrequency electromagnet fields as possibly carcinogenic (cancer-causing) to humans. The European Union defined basic restrictions for limiting exposure to electromagnetic fields in Council Recommendation 1999/519/EC, setting maximum values that should not to be exceeded. Moreover, in view of the scientific uncertainty, the European Environment Agency advises taking a precautionary approach. Two sets of large-scale experimental studies involving laboratory animals, one from the United States National Toxicology Program and another from the Italian Ramazzini Institute, have recently brought the debate to the fore again. Both found varying levels of evidence of certain tumours in some of the animals tested. The results have nevertheless prompted diverging conclusions.

Sampling points for air quality - Representativeness and comparability of measurement in accordance with Directive 2008/50/EC on ambient air quality and cleaner air for Europe

18-03-2019

Air quality monitoring at fixed sites is a major instrument provided for in the Ambient Air Quality Directive to check compliance with limit or target values, which have been set for the protection of human health. This study analyses the criteria for the location of monitoring sites in five Member States to identify ambiguous provisions that might lead to different assessments of air pollution exposure. This document was provided by Policy Department A at the request of the Committee on the Environment ...

Air quality monitoring at fixed sites is a major instrument provided for in the Ambient Air Quality Directive to check compliance with limit or target values, which have been set for the protection of human health. This study analyses the criteria for the location of monitoring sites in five Member States to identify ambiguous provisions that might lead to different assessments of air pollution exposure. This document was provided by Policy Department A at the request of the Committee on the Environment, Public Health and Food Safety of the European Parliament.

Extern avdelning

Christian NAGL, Wolfgang SPANGL, Iris BUXBAUM

Endocrine Disruptors: From Scientific Evidence to Human Health Protection

15-01-2019

This study, commissioned by the PETI Committee of the European Parliament, presents the scientific knowledge regarding the health effects of endocrine disruptors, a class of hazards recognized in EU regulation since 1999. This report reviews the scientific evidence regarding the concept of endocrine disruption, the extent of exposure, associated health effects and costs. The existing relevant EU regulations are discussed and recommendations made to better protect human health.

This study, commissioned by the PETI Committee of the European Parliament, presents the scientific knowledge regarding the health effects of endocrine disruptors, a class of hazards recognized in EU regulation since 1999. This report reviews the scientific evidence regarding the concept of endocrine disruption, the extent of exposure, associated health effects and costs. The existing relevant EU regulations are discussed and recommendations made to better protect human health.

Extern avdelning

Barbara DEMENEIX, PhD, UMR 7221 CNRS/MNHN, Muséum National d’Histoire Naturelle, Paris, France. Rémy SLAMA, PhD, Senior Investigator, INSERM (National Institute of Health and Medical Research), IAB Research Center, Team of Environmental Epidemiology, Grenoble, France.

Protection of workers from exposure to carcinogens or mutagens: Third proposal

17-12-2018

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research centres, publishers and international organisations, making the overall analysis sufficiently convincing and robust. As regards the limitations of the analysis, which are transparently acknowledged, the analysis carried out by the external contractors and endorsed in the IA recognises that the full current and future disease burden deriving from historic exposures to cadmium and beryllium is not captured; consequently, the disease burdens may be underestimated. As regards the estimated number of workers exposed to cadmium, the value of 10 000 workers considered by the external contractors for their modelling (in addition to a higher value of 30 000), and taken over in the IA, is coherently justified in light of the recognised wide divergences among the different estimates. This value appears to be reasonable, based on the availability of data at national and EU level, and the way some of them were gathered. As regards the estimated number of workers exposed to beryllium, the figure of 54 071 workers exposed in the EU 28 (excluding the construction sector) identified by the external contractor and used in the IA appears to be plausible, based on the justifications provided. However, it is acknowledged that higher exposure levels would imply higher costs and benefits at all target OEL values.

Protecting workers against carcinogens and mutagens: Second proposal

05-12-2018

The European Commission has started a phased process to amend Directive 2004/37/EC (Carcinogens and Mutagens Directive, CMD), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The second proposal to amend the CMD addresses a further seven agents. It is among the Joint Declaration initiatives Parliament, Council and Commission have committed to handle with priority. The agreement on the proposal reached ...

The European Commission has started a phased process to amend Directive 2004/37/EC (Carcinogens and Mutagens Directive, CMD), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The second proposal to amend the CMD addresses a further seven agents. It is among the Joint Declaration initiatives Parliament, Council and Commission have committed to handle with priority. The agreement on the proposal reached after trilogue negotiations now needs a confirmation vote, expected to take place during the December plenary session.

Directive 2009/128/EC on the sustainable use of pesticides

19-10-2018

The study presents the results of evaluation of the implementation of the Directive 2009/128/EC establishing a framework for Community action to achieve the sustainable use of pesticides. The study was outsourced and prepared by a consortium led by ÖIR GmbH, in collaboration with Arcadia International, t33 and external experts. The study covers the implementation of the directive as a whole. Furthermore, it concentrates on the implementation of the integrated pest management principles in the individual ...

The study presents the results of evaluation of the implementation of the Directive 2009/128/EC establishing a framework for Community action to achieve the sustainable use of pesticides. The study was outsourced and prepared by a consortium led by ÖIR GmbH, in collaboration with Arcadia International, t33 and external experts. The study covers the implementation of the directive as a whole. Furthermore, it concentrates on the implementation of the integrated pest management principles in the individual Member States. In addition, it also provides an analysis concerning of a the development of harmonised risk indicators, the imposition of limitation and bans of on the usage of pesticides in sensitive specific sensitive areas, and the impacts that of the use of pesticides has on drinking water. The analysis is accompanied by recommendations on how to improve the implementation processes.

Kommande evenemang

03-06-2020
EPRS online Book Talk | One of Them: From Albert Square to Parliament Square
Övrigt -
EPRS
11-06-2020
CONT Public Hearing: Implementation of EU funds
Utfrågning -
CONT
15-06-2020
EPRS online Book Talk | A Certain Idea of France: The life of Charles de Gaulle
Övrigt -
EPRS

Partner